PS
Piper Sandler Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
951
Pacira BioSciences
PCRX
$1.2B
|
DA
David Amsellem
| $26.30 | $42 |
60%
upside
| Overweight |
3 Jul ‘24
1 year ago |
|
952
Crinetics Pharmaceuticals
CRNX
$3.31B
|
YR
Yasmeen Rahimi
| $36.50 | $97 |
166%
upside
| Overweight |
2 Jul ‘24
1 year ago |
|
953
Praxis Precision Medicines
PRAX
$858M
|
YR
Yasmeen Rahimi
| $40.03 | $270 |
574%
upside
| Overweight |
1 Jul ‘24
1 year ago |
|
954
Taysha Gene Therapies
TSHA
$884M
|
CR
Christopher Raymond
| $3.28 | $7 |
113%
upside
| Overweight |
1 Jul ‘24
1 year ago |
|
955
Zimmer Biomet
ZBH
$20.7B
|
MO
Matthew O'Brien
| $103.85 | $115 |
11%
upside
| Neutral |
1 Jul ‘24
1 year ago |
|
956
Monte Rosa Therapeutics
GLUE
$296M
|
ET
Edward Tenthoff
| $4.83 | $16 |
231%
upside
| Overweight |
28 Jun ‘24
1 year ago |
|
957
Apple
AAPL
$3.48T
|
HK
Harsh Kumar
| $234.35 | $250 |
7%
upside
| Outperform |
28 Jun ‘24
1 year ago |
|
958
Dynatrace
DT
$15.1B
|
RO
Rob Owens
| $50.65 | $50 |
1%
downside
| Neutral |
27 Jun ‘24
1 year ago |
|
|
TECX
959
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
|
YR
Yasmeen Rahimi
| $17.22 | $76 |
341%
upside
| Overweight |
26 Jun ‘24
1 year ago |
|
960
Altimmune
ALT
$327M
|
YR
Yasmeen Rahimi
| $3.78 | $25 |
561%
upside
| Overweight |
21 Jun ‘24
1 year ago |
|
961
Ocular Therapeutix
OCUL
$2.21B
|
BA
Biren Amin
| $12.76 | $15 |
18%
upside
| Overweight |
21 Jun ‘24
1 year ago |
|
962
Fate Therapeutics
FATE
$111M
|
ET
Edward Tenthoff
| $0.9799 | $6 |
512%
upside
| Overweight |
17 Jun ‘24
1 year ago |
|
|
963
Ocular Therapeutix
OCUL
$2.21B
|
JC
Joseph Catanzaro
| $12.76 | $15 |
18%
upside
| Overweight |
14 Jun ‘24
1 year ago |
|
964
Benitec Biopharma
BNTC
$363M
|
YR
Yasmeen Rahimi
| $13.99 | $30 |
114%
upside
| Overweight |
13 Jun ‘24
1 year ago |
|
965
Nurix Therapeutics
NRIX
$742M
|
JC
Joseph Catanzaro
| $9.20 | $35 |
280%
upside
| Overweight |
5 Jun ‘24
1 year ago |
|
966
WaFd
WAFD
$2.48B
|
KH
Kashy Harrison
| $31.49 | $31 |
2%
downside
| Neutral |
20 May ‘24
1 year ago |
|
967
Context Therapeutics
CNTX
$73.7M
|
JC
Joseph Catanzaro
| $0.8455 | $4.50 |
432%
upside
| Overweight |
16 May ‘24
1 year ago |
|
968
Rithm Capital
RITM
$6.63B
|
KB
Kevin Barker
| $12.53 | $12.50 |
0%
downside
| Neutral |
14 May ‘24
1 year ago |
|
969
Banc of California
BANC
$2.65B
|
MC
Matthew Clark
| $16.79 | $19 |
13%
upside
| Overweight |
13 May ‘24
1 year ago |
|
970
Alphatec Holdings
ATEC
$2.42B
|
MO
Matthew O'Brien
| $15.80 | $17 |
8%
upside
| Overweight |
8 May ‘24
1 year ago |
|
971
Design Therapeutics
DSGN
$331M
|
YR
Yasmeen Rahimi
| $6.64 | $12 |
81%
upside
| Overweight |
7 May ‘24
1 year ago |
|
972
Chart Industries
GTLS
$8.98B
|
IM
Ian Macpherson
| $199.34 | $160 |
20%
downside
| Neutral |
6 May ‘24
1 year ago |
|
973
TechnipFMC
FTI
$16.1B
|
LL
Luke Lemoine
| $39.65 | $34 |
14%
downside
| Overweight |
6 May ‘24
1 year ago |
|
974
Wendy's
WEN
$1.89B
|
AG
Aisling Grueninger
| $9.92 | $23 |
132%
upside
| Overweight |
3 May ‘24
1 year ago |
|
|
FLG
975
Flagstar Financial, Inc.
FLG
$5.35B
|
MF
Mark Fitzgibbon
| $12.61 | $12 |
5%
downside
| Overweight |
1 May ‘24
1 year ago |
|